ARCHIVES

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

This article is from The Cancer Letter archive.

Vol. 17 No. 31 | August 2, 1991

Download PDF Visit The Full Archive

Related Articles

In Brief: Harvard’s Richmond Said To Be The Choice As Asst. secretary; Lee Clark Convalescing

May 6, 1977

Hutchinson Center Receives NCI Grant For Immunotherapy Network

October 15, 2010

Bypass Budget Is Realistic, Defensible Plan, Broder Says

September 27, 1991

Cullen Credits Staff With Success Of STCP, Strong Prevention Program a NCI

May 19, 1989

Clinical Cooperative Groups Asked To Develop Tamoxifen Prevention Trial; CGOPs To Participate

July 6, 1990

New Subcommittee Chairman Named

June 10, 1977